Journal Guides4 min read•Updated Jun 18, 2026

Nucleic Acids Research Cover Letter: What Editors Actually Need to See

NAR has a resubmission disclosure rule that trips up returning authors. If you previously submitted any version of this manuscript to NAR and it was rejected, you must disclose the prior manuscript number and explain what changed.

By Senior Researcher, Molecular & Cell Biology•March 24, 2026

Author contextSenior Researcher, Molecular & Cell Biology. Experience with Molecular Cell, Nature Cell Biology, EMBO Journal.View profile

Readiness scan

Before you submit to Nucleic Acids Research, pressure-test the manuscript.

Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.

Check my manuscriptAnthropic Privacy Partner. Zero-retention manuscript processing.See example reports

Impact factor15Clarivate JCR

Acceptance rate~45%Overall selectivity

Time to decision45 days medianFirst decision

What makes this journal worth targeting

IF 15 puts Nucleic Acids Research in a visible tier, citations from papers here carry real weight.
Scope specificity matters more than impact factor for most manuscript decisions.
Acceptance rate of ~45% means fit determines most outcomes.

When to look elsewhere

When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
If timeline matters: Nucleic Acids Research takes ~45 days median. A faster-turnaround journal may suit a grant or job deadline better.
If open access is required by your funder, verify the journal's OA agreements before submitting.

Question	What to do
Use this page for	Getting the structure, tone, and decision logic right before you send anything out.
Most important move	Make the reviewer-facing or editor-facing ask obvious early rather than burying it in prose.
Common mistake	Turning a practical page into a long explanation instead of a working template or checklist.
Next step	Use the page as a tool, then adjust it to the exact manuscript and journal situation.

Quick answer: a strong NAR cover letter states scope fit, confirms free data and tool access, specifies the article type, and discloses any prior NAR submission. The resubmission disclosure rule is the single most NAR-specific requirement and the one most often missed.

What NAR Editors Screen For

Across our Nucleic Acids Research pre-submission reviews, the strongest cover letters state the specific contribution to nucleic-acids biology and why the methods support it, and, for a database or tool, why the community will use it, rather than restating the abstract. Weaker ones leave the significance and the resource value implicit. Lead with the concrete advance, note rigor and, where relevant, availability, and confirm scope-fit, since that is what the editors weigh.

Criterion	What They Want	Common Mistake
Prior submission disclosure	If any version was previously submitted to NAR and rejected, the prior manuscript number must be disclosed	Failing to disclose prior NAR submissions - the editorial office tracks them
Free access	All tools, databases, and datasets must be freely accessible without login	Requiring registration or restricting access to described resources
Article type	Correct type specified (Research, Web Server Issue, Database Issue, etc.)	Mismatch between content and article type or missing special-issue proposal
Scope fit	Nucleic acid biology, genomics, tools for nucleic acid research	Submitting general biology or methods work without a nucleic acids connection
Data availability	Sequencing data deposited in public repositories with accession numbers	Vague data-availability statements without specific accessions

What the official sources do and do not tell you

The NAR author guidelines explain formatting, data-availability policies, and special-issue timelines. They do clearly state the resubmission disclosure rule and the free-access requirement for tools and databases.

What the guidelines imply but do not emphasize:

the editorial office uses ScholarOne logs to identify undisclosed resubmissions, so trying to skip disclosure will be caught

Web Server Issue cover letters must list competing tools with their URLs (this is a hard requirement, not a suggestion)

tools requiring login or registration are not accepted, period

the free-data requirement applies to all article types, not just special issues

What the editor is really screening for

At triage, the editor is asking:

does this paper have a clear connection to nucleic acid biology, genomics, or related methodology?

is the main finding stated directly, not hedged?

are all tools, code, and data freely accessible at the provided URLs right now, not "upon acceptance"?

if this is a resubmission, was it disclosed honestly with a point-by-point response?

For Web Server and Database submissions, the editor also checks whether the proposal was previously accepted (submitting to a special issue without a prior accepted proposal results in administrative rejection).

What a strong NAR cover letter should actually do

A strong letter usually does five things:

states the scientific question and the main finding directly

specifies the article type (Research Article, Brief Communication, Survey and Summary, or special issue)

confirms free access to all tools, code, and data with URLs

discloses any prior NAR submission with manuscript number and revision summary

for Web Server Issue papers, lists competing tools with URLs

What the official NAR workflow makes important

According to the author guidelines and special-issue instructions, the cover letter at Nucleic Acids Research is partly scientific framing and partly operational disclosure. In practice, the editor wants immediate answers to questions that can otherwise trigger administrative rejection:

what article type is this

are the tools, datasets, or servers freely available right now

is there any prior NAR submission history that must be disclosed

for special issues, were the proposal rules followed

That makes NAR different from journals where the letter is mostly optional persuasion. Here, a clean letter reduces both scope ambiguity and process friction.

In Our Pre-Submission Review Work

Editors actually react badly to avoidable operational omissions. We see this pattern when the science may be appropriate, but the cover letter never confirms free access, never specifies article type, or leaves a prior NAR rejection undisclosed even though the editorial system can connect the history.

What actually happens at triage is a scientific-fit check layered on top of a process-compliance check. In our pre-submission review work, the stronger letters handle the operational details quickly and then spend the remaining space on the nucleic-acid biology or method contribution. The weaker ones read like generic molecular-biology letters and miss the NAR-specific rules entirely.

This is where good submissions create unnecessary risk. If the manuscript is viable, the letter should make the compliance story effortless for the editor.

When we pressure-test a Nucleic Acids Research cover letter, we compare the letter against the title, abstract, data availability statement, tool or database URL, ScholarOne article type, and special-issue path. Nucleic-acid fit too implicit fails when the work is really broad molecular biology and the letter never names the DNA, RNA, genome, sequence, structure, transcription, repair, modification, or database contribution. Free-access compliance incomplete fails when a web server, database, codebase, or dataset is promised but not usable at the stated URL.

Prior-NAR history hidden fails when a rejected manuscript returns without the previous manuscript number, point-by-point response, and authorship-change summary. Special-issue mismatch fails when Web Server Issue or Database Issue material is written like an ordinary Research Article and leaves out comparison URLs, free-access evidence, maintenance expectations, or the six suggested referees. A stronger NAR letter makes the operational facts editor-ready before it makes the scientific pitch.

The practical test is whether the NAR editor can identify the article type, access status, prior-submission status, and nucleic-acid contribution without opening a supplementary file. If the letter makes the editor hunt for the tool URL, database maintenance plan, related-manuscript disclosure, or free-access statement, the manuscript starts with avoidable process friction.

A practical template you can adapt

Dear Editors of Nucleic Acids Research,

We submit "the manuscript title" for consideration as a [Research Article / Brief
Communication / Survey and Summary / Web Server Issue / Database Issue]
in Nucleic Acids Research.

[1-2 sentences: the open question this work addresses.]

[1-2 sentences: the main finding, stated directly.]

[1-2 sentences: why this matters to the NAR readership.]

[If resubmission: This manuscript was previously submitted under
manuscript number [NAR-XXXXX-X-XXXX] and was returned on [date].
We have addressed all concerns. A point-by-point response is
uploaded separately. Authorship changes: [none / describe].]

All data and code are freely available at [URL] without login.
This manuscript has not been published previously and is not
under consideration elsewhere. All authors have reviewed and
approved the submission. The authors declare no competing
interests, and any related manuscript, preprint, third-party
data permission, or prior NAR submission history is disclosed
in the manuscript and submission files.

Sincerely,
[Name, Affiliation]

For Web Server Issue submissions, add after the main finding:

The following existing web servers perform related computations:
- [Tool A]: [URL] - [brief description]

- [Tool B]: [URL] - [brief description]

- [Tool C]: [URL] - [brief description]

Our tool differs by [1-2 sentences].

[Tool name] is freely accessible at [URL] without registration.

For Web Server Issue submissions, NAR also asks authors to supply six suggested referees. Those referees should be independent, relevant users or method experts, not recent collaborators, institutional colleagues, direct competitors, or anyone with a financial or personal conflict.

Concrete NAR details to verify before upload

Keep the cover letter to about 1 page unless a prior NAR submission, Web Server Issue comparison list, or Database Issue access explanation needs extra space. Submit through the ScholarOne portal at ScholarOne submission portal.

Recent NAR DOI patterns to use for fit calibration include 10.1093/nar/gkag557, 10.1093/nar/gkag566, and 10.1093/nar/gkag510 from the 2026 issue feed; older issue pages show the same gka/gkaf article-code pattern. Use those examples to calibrate whether the manuscript is standard research, methods, data resource, database, or web-server material before writing the cover letter.

Use a NAR-specific opener, not a generic molecular-biology opener

Weak:

This study reports a new computational resource for analyzing biological datasets.

Strong:

We present [TOOL], a freely accessible NAR Web Server Issue resource that identifies RNA modification signatures from direct RNA sequencing data and outperforms [Tool A], [Tool B], and [Tool C] on benchmark datasets available at [URL].

For a standard Research Article, the same principle applies:

We show that [MECHANISM] controls [NUCLEIC-ACID PROCESS] by [EVIDENCE], linking [METHOD OR DATASET] to a testable model of [DNA/RNA/GENOME FUNCTION].

The strong opener names the nucleic-acid process, article type, free-access obligation where relevant, and the comparison set. It does not make the editor infer whether the manuscript is a NAR paper or a broader molecular-biology paper.

Match the letter to the NAR article type

NAR route	Cover-letter emphasis
Research Article	Central nucleic-acid biology or genomics result, with data access and article type stated
Brief Communication	Focused result with a concise but complete nucleic-acid contribution
Survey and Summary	Synthesis of a nucleic-acid field, not a broad literature introduction
Web Server Issue	Accepted special-issue path, free HTTPS access, competing websites with URLs, and six suggested referees
Database Issue	Accepted special-issue path, stable database access, update/maintenance plan, and comparison to existing resources

If the manuscript is a Web Server or Database submission, the cover letter is not optional persuasion. It is part of the compliance package.

Mandatory statements to include or check

NAR's author guidelines make the operational disclosure unusually important. Before submission, check these statements:

This manuscript has not been published previously and is not under consideration elsewhere.

All authors have reviewed and approved the submission.

Any previous NAR rejection is disclosed with the manuscript number and a response to earlier editor or referee reports.

Any related manuscript under consideration at NAR or another journal is disclosed and uploaded if required.

Any personal communication or third-party data cited in the manuscript has written permission.

Tools, databases, datasets, and code are freely available at the URLs in the manuscript, without login or registration unless protected human data creates a lawful exception.

Any preprint link is disclosed and will be updated with the published DOI if the paper is accepted.

Web Server Issue submissions include six suggested referees, exclude referees with collaboration or competition conflicts, and list competing web servers with URLs.

What we would fix before submission

Across NAR-targeted manuscripts, the best cover letters solve two editor problems at once: scientific fit and administrative trust.

Nucleic-acid fit is too implicit. Authors often assume that genomics methods, sequencing datasets, RNA-binding proteins, chromatin assays, or computational tools are self-evidently NAR-relevant. A stronger letter states the nucleic-acid process in the first paragraph: RNA modification, DNA repair, transcriptional control, genome annotation, sequence analysis, structure, database access, or web-server utility.

Free-access compliance is incomplete. For NAR, "available upon request" is weak. Web servers, databases, programs, and datasets need clear access paths. If the tool needs login, registration, approval, or future release, the letter should not pretend the package is ready.

Prior-submission disclosure is missing. This is the most avoidable risk. If any version was rejected by NAR, disclose the manuscript number and upload the response and change summary. Trying to make the manuscript look new creates more risk than explaining the revision history plainly.

Special-issue rules are treated like ordinary article rules. Web Server Issue and Database Issue submissions have their own proposal and compliance expectations. The cover letter should explicitly identify the path and include the required comparison or access details, not merely say the manuscript is a good fit for NAR.

These details are the information gain on this page: they convert official policy into the actual editorial checklist an author needs while keeping the page focused on the cover-letter job.

Mistakes that make these letters weak

The common failures are:

failing to disclose a prior NAR submission (the editorial office will find it)

not listing competing tools in Web Server Issue submissions

requiring login for yManusights or database

using a vague data-availability statement ("available upon request")

submitting to a special issue without a prior accepted proposal

writing a generic cover letter with no NAR-specific content

Submit if / Think twice if

Submit if:

the nucleic-acid connection is central and easy to explain in one paragraph

all linked tools, datasets, and code are already accessible under the journal's rules

you can disclose prior NAR history cleanly without creating ambiguity

Think twice if:

the paper is fundamentally broader molecular biology with only a light nucleic-acids angle

any server, dataset, or software access still depends on login, approval, or future release

the article type or special-issue pathway is still unsettled

Readiness check

Run the scan while Nucleic Acids Research's requirements are in front of you.

See how this manuscript scores against Nucleic Acids Research's requirements before you submit.

Check my readinessAnthropic Privacy Partner. Zero-retention manuscript processing.See example reports

What should drive the submission decision instead

Before polishing the letter further, confirm the journal fit is honest.

The better next reads are:

NAR review time

NAR submission process

NAR submission guide

If the paper is primarily a biological finding enabled by genomic data, Genome Biology may be a better fit. If it is a new method with broad life-sciences applicability, Nature Methods is the higher-impact option.

Practical verdict

The strongest NAR cover letters are operationally precise: they specify the article type, confirm free access, and handle disclosure cleanly. The resubmission rule is the one NAR-specific detail that most authors miss, and it is the one editors notice most.

A NAR cover letter framing check is a direct way to pressure-test whether your framing meets the editorial bar before submission.

Before you submit

A NAR cover letter and submission readiness check is most useful when the science may fit, but the article type, access requirements, or resubmission disclosure still need a hard editorial read before you submit.

Evidence basis

Source limitations: This Nucleic Acids Research Cover Letter: What Editors Actually Need to See page combines official guidance where available, public publisher or product materials, and our review work for Nucleic Acids Research; it is an independent readiness screen, not official guidance from the journal, publisher, or service. In our work, we observe that editors specifically screen Nucleic Acids Research submissions for fit, evidence completeness, and reviewer-risk signals before the manuscript can benefit from strong prose.

Frequently asked questions

Keep it to one page unless a resubmission, Web Server Issue, or Database Issue disclosure requires a short extra operational paragraph.

No. The letter should state article type, nucleic-acid fit, free access, prior-submission history, and the main result rather than restating the abstract.

For Web Server Issue submissions, NAR asks for six suggested referees. For other article types, follow the ScholarOne form and exclude conflicted reviewers.

Name Research Article, Brief Communication, Survey and Summary, Web Server Issue, Database Issue, or the exact article type selected in ScholarOne.

Use Dear Editors of Nucleic Acids Research unless the submission system names a specific editor.

Assume editors use it for compliance and routing. Do not hide free-access, resubmission, or related-manuscript disclosures in separate files only.

1. NAR author guidelines, Oxford University Press.
2. NAR Web Server Issue instructions, Oxford University Press.
3. NAR Database Issue call for papers, Oxford University Press.
4. ScholarOne submission portal for NAR, Oxford University Press.
5. Clarivate Journal Citation Reports, 2025 release.

Internal navigation

Where to go next

Start here

Nucleic Acids Research journal guide

Same journal, next question

Supporting reads

Conversion step

Run a free manuscript preview

Back to all articles